What does a serum iron of 74.6 µg/dL, transferrin saturation of 14 %, and total iron‑binding capacity of 531 µg/dL indicate, and what management is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Iron Deficiency Indicated – Initiate Iron Replacement Therapy

Your laboratory values indicate iron deficiency: a transferrin saturation of 14% (below the diagnostic threshold of <16-20%) combined with an elevated TIBC of 531 µg/dL confirms depleted iron stores and inadequate iron availability for red blood cell production. 1

Understanding Your Results

Your iron studies show a classic pattern of iron deficiency:

  • Serum iron 74.6 µg/dL: Low circulating iron
  • Transferrin saturation 14%: Well below the 16-20% threshold used to confirm iron deficiency 1
  • TIBC 531 µg/dL: Elevated, indicating your body is producing more transferrin (iron-binding protein) to capture whatever iron is available 1

The elevated TIBC occurs specifically when iron stores are depleted – your body compensates by increasing iron-binding capacity to maximize iron uptake 1. This pattern has 93% specificity for true iron deficiency 1.

Essential Next Steps

1. Confirm with Serum Ferritin

You need a serum ferritin level to complete the diagnosis:

  • Ferritin <15 µg/L: Confirms absolute iron deficiency 1
  • Ferritin 15-30 µg/L: Still consistent with iron deficiency in most patients 2, 3
  • Ferritin >100 µg/L: Makes iron deficiency unlikely unless you have chronic inflammation, kidney disease, or heart failure 4

2. Check Hemoglobin/Hematocrit

Determine if you have:

  • Iron deficiency anemia (IDA): Low hemoglobin with iron deficiency
  • Non-anemic iron deficiency: Normal hemoglobin but depleted iron stores

Both require treatment, as iron deficiency causes fatigue, exercise intolerance, restless legs, and cognitive difficulties even without anemia 3.

3. Identify the Underlying Cause

Iron deficiency doesn't occur in isolation. Investigate:

Gastrointestinal blood loss (most common in adults):

  • Upper and lower endoscopy warranted in most adults with confirmed iron deficiency 4, 5
  • Check for celiac disease (small bowel biopsy during upper endoscopy) – present in 2-3% of IDA patients 5
  • Consider H. pylori testing 2

Menstrual blood loss in premenopausal women:

  • Heavy menstrual bleeding is the leading cause in this population 3

Malabsorption conditions:

  • Prior gastric surgery, bariatric procedures
  • Inflammatory bowel disease
  • Atrophic gastritis 3

Medications:

  • NSAIDs, aspirin, anticoagulants increase GI bleeding risk 4, 5

Treatment Recommendations

Start with Oral Iron (First-Line for Most Patients)

Ferrous sulfate 325 mg daily or every other day is the standard initial therapy 4, 3:

  • Take on an empty stomach for best absorption (or with food if not tolerated) 2
  • Adding 500 mg vitamin C enhances absorption 2
  • Alternate-day dosing may improve tolerance with similar efficacy 3

Common side effects: Nausea, constipation, abdominal discomfort – occur in many patients and limit adherence 4, 2.

Use Intravenous Iron When:

You should receive IV iron instead of oral iron if you have 4, 3:

  • Chronic kidney disease (especially if on dialysis or receiving erythropoietin)
  • Chronic heart failure (oral iron poorly absorbed due to gut edema; IV iron has prognostic benefit)
  • Inflammatory bowel disease with moderate-severe anemia (Hb <100 g/L)
  • Intolerance to oral iron (persistent GI side effects)
  • Malabsorption (celiac disease, post-bariatric surgery)
  • Ongoing blood loss that exceeds oral replacement capacity
  • Pregnancy (second or third trimester)

In these conditions, IV iron is more effective and often necessary to achieve adequate iron repletion 4, 3.

Important Caveats

Transferrin saturation has significant variability:

  • Diurnal variation (higher in morning) 1
  • Increases after meals 1
  • Decreases with infection or inflammation 1

If you have chronic inflammatory conditions (kidney disease, heart failure, inflammatory bowel disease, cancer), interpret results differently:

  • Iron deficiency can exist with ferritin up to 100 µg/L 4
  • Transferrin saturation <20% with ferritin <100 µg/L indicates absolute iron deficiency in these populations 4

Do not assume dietary insufficiency alone explains your iron deficiency – even with poor dietary intake, full GI investigation is still required in adults to exclude occult bleeding or malabsorption 5.

Monitoring Response

After starting iron therapy:

  • Recheck hemoglobin in 2-4 weeks (should see improvement)
  • Continue treatment for 3-6 months to replete iron stores
  • Recheck ferritin after treatment completion
  • Monitor for recurrence, especially if underlying cause persists 4

References

Related Questions

What does an iron panel showing total iron‑binding capacity 368 µg/dL, ferritin 15 µg/L, serum iron 128 µg/dL, and transferrin saturation 35% indicate, and how should it be managed?
What is the significance and recommended management of an isolated total iron‑binding capacity of 450 µg/dL with normal serum iron, ferritin, and transferrin saturation?
My iron studies show total iron 70 mcg/dL (reference 40‑190), total iron‑binding capacity 364 mcg/dL (reference 250‑450), transferrin saturation 19 % (reference 16‑45), and ferritin 15 ng/mL (reference 16‑154). What does this indicate and what should I do?
Do the iron studies—total iron‑binding capacity 246 µg/dL, transferrin saturation 30 %, ferritin 85 ng/mL—indicate normal iron status or suggest deficiency or overload?
How should I interpret serum iron 52 µg/dL, transferrin saturation 12 %, ferritin 9 ng/mL, and what treatment is recommended?
What are the long‑term treatment options for polymyositis?
When should rituximab be used in adult patients with polymyositis, and what is the recommended dosing and monitoring protocol?
Can I feel depressed after stopping Latuda (lurasidone)?
What are the classifications of Parkinsonism and how is disease severity staged (e.g., Hoehn‑Yahr scale)?
What is the maximum dose of carvedilol in patients with liver cirrhosis?
How should iron deficiency be treated in a patient with normal hemoglobin, hematocrit, and mean corpuscular volume?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.